Healthcare Global Enterprises Limited

Healthcare · Healthcare Services

NSE: HCG BSE: 539787

₹666.05

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #17 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	117,407	74.7	20.1%	9.7%	—	73	0	27
Max Healthcare Institute Limited	90,492	126.0	13.4%	-16.5%	0.22%	77	0	26
Fortis Healthcare Limited	58,132	257.5	10.5%	-22.2%	0.13%	49	26	6
Global Health Limited	36,701	76.2	13.9%	4.6%	0.04%	74	0	30
Narayana Hrudayalaya Ltd.	36,609	64.4	17.8%	3.5%	0.25%	66	0	29
Aster DM Quality Care Limited	36,121	207.5	8.8%	10.5%	0.43%	53	0	26
Dr. Lal Path Labs Ltd.	33,310	38.7	20.1%	-37.3%	0.98%	82	0	88
Krishna Institute of Medical Sciences Limited	31,349	111.2	9.5%	8.5%	—	47	0	29
Healthcare Global Enterprises Limited (this stock)	9,944	569.3	1.6%	2.5%	—	31	22	30

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹10,037 Cr

EV / EBITDA

44.2x

EV / Sales

7.09x

Market cap / Sales

7.03x

Earnings yield

0.18%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 386 Cr, up 15.3% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 6 Cr, up 61.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	377	7	6	₹0.3700
March 31, 2026	350	-9	2	₹0.1100
Dec. 31, 2025	342	-1	-1	₹-0.0800
Sept. 30, 2025	346	15	11	₹0.7700
June 30, 2025	327	5	3	₹0.2500
March 31, 2025	324	17	10	₹0.7300
Dec. 31, 2024	312	-36	-37	₹-2.6800
Sept. 30, 2024	307	21	16	₹1.1500
June 30, 2024	294	15	12	₹0.8400
March 31, 2024	280	4	-2	₹-0.1300
Dec. 31, 2023	267	15	8	₹0.6000
Sept. 30, 2023	283	18	14	₹0.9800
June 30, 2023	272	18	14	₹0.9800

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	386	365	345	350	335	334	318	317	304	284	273	285	274
Operating revenue	377	350	342	346	327	324	312	307	294	280	267	283	272
Other income	10	15	3	4	8	9	6	10	10	4	6	2	2
Operating expenses	317	275	288	284	277	265	270	249	244	226	220	232	225
Operating profit	59	75	54	62	50	59	41	58	50	55	47	50	48
Operating profit margin	15.7%	21.5%	15.9%	18.0%	15.2%	18.2%	13.3%	18.9%	17.0%	19.6%	17.5%	17.8%	17.5%
Depreciation	40	31	30	30	28	29	28	27	26	25	24	23	22
Interest	22	20	21	21	24	22	21	20	19	14	13	11	10
Exceptional items, gain / (loss)	—	-48	-8	—	—	—	-35	—	—	-16	—	—	—
Profit before tax	7	-9	-1	15	5	17	-36	21	15	4	15	18	18
Tax	2	-10	-0	4	2	7	1	5	3	5	7	5	4
Net profit	6	—	—	11	3	10	-37	16	12	-2	8	14	14
EPS	0.37	0.11	-0.08	0.77	0.25	0.73	-2.68	1.15	0.84	-0.13	0.60	0.98	0.98
Net profit (TTM)	—	—	—	-13	-8	1	-11	34	32	34	40	46	43
EPS (TTM)	1.17	1.05	1.67	-0.93	-0.55	0.04	-0.82	2.46	2.29	2.43	2.86	3.28	3.09

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,365	10	15
March 31, 2025	1,280	20	4
March 31, 2024	1,103	55	34
March 31, 2023	1,008	58	40

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	11.1%	17.1%	1,395^†	1,317^†	1,116^†	1,016^†	862^†	633^†	700^†	654^†	591^†	165^†
Operating revenue	10.7%	17.4%	1,365	1,280	1,103	1,008	852^†	611^†	690^†	641^†	575^†	158^†
Other income	—	—	30^†	36^†	14^†	9^†	10^†	22^†	11^†	13^†	17^†	7^†
Operating expenses	—	—	1,124^†	1,028^†	903^†	825^†	703^†	535^†	573^†	546^†	—	—
Operating profit	9.8%	26.1%	242^†	252^†	200^†	182^†	149^†	76^†	117^†	95^†	—	—
Operating profit margin	—	—	17.7%^†	19.7%^†	18.1%^†	18.1%^†	17.5%^†	12.4%^†	17.0%^†	14.8%^†	—	—
Depreciation	—	—	120^†	110^†	94^†	89^†	88^†	87^†	79^†	47^†	—	—
Interest	—	—	86^†	83^†	48^†	41^†	43^†	63^†	83^†	48^†	26^†	15^†
Exceptional items, gain / (loss)	—	—	-55^†	-35^†	-16^†	-3^†	53^†	-153^†	-31^†	0^†	3^†	0^†
Profit before tax	-44.9%	—	10	20	55	58	81^†	-205^†	-65^†	13^†	39^†	35^†
Tax	—	—	-5^†	16^†	21^†	17^†	43^†	-14^†	-12^†	5^†	14^†	12^†
Net profit	-28.7%	—	15	4	34	40	38^†	-192^†	-53^†	7^†	25^†	24^†
EPS	-28.6%	—	1.05^†	0.04^†	2.43^†	2.89^†	3.28^†	-15.92^†	-6.01^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	17.7%^†	19.7%^†	18.1%^†	18.1%^†	17.5%^†	12.4%^†	17.0%^†	14.8%^†	—	—
EBIT margin	7.0%^†	8.0%^†	9.3%^†	9.8%^†	14.5%^†	-23.3%^†	2.5%^†	9.4%^†	11.3%^†	31.4%^†
PBT margin	0.7%	1.5%	5.0%	5.7%	9.5%^†	-33.6%^†	-9.5%^†	2.0%^†	6.8%^†	22.2%^†
Net margin	1.1%	0.3%	3.1%	4.0%	4.5%^†	-31.3%^†	-7.7%^†	1.1%^†	4.4%^†	14.9%^†
Interest coverage	1.11x^†	1.24x^†	2.14x^†	2.39x^†	2.89x^†	-2.26x^†	0.21x^†	1.26x^†	2.51x^†	3.41x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.60x	1.03x	—	—	—	—	—	—	—	—
Quick ratio	1.55x	1.00x	—	—	—	—	—	—	—	—
Debt to equity	0.35x	0.55x	—	—	—	—	—	—	—	—
Return on equity	0.9%	0.3%	—	—	—	—	—	—	—	—
Return on assets	0.5%	0.1%	—	—	—	—	—	—	—	—
Return on capital employed	4.0%^†	5.2%^†	—	—	—	—	—	—	—	—
Asset turnover	0.47x	0.49x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	160	-76	336	154	6
March 31, 2025	146	-347	-42	133	13
March 31, 2024	195	-249	105	125	70
March 31, 2023	130	-138	-42	102	28
March 31, 2022	124	49	-41	42	82

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	2,917	1,605	1,455	252	315	849	530	474	1,025	25
March 31, 2025	2,604	1,191	1,052	348	304	640	623	158	935	20
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.